NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI): Form 8-K filed 2026-11-13
- Accepted by EDGAR
- 2026-11-13 17:00 ET
- Event date
- 2026-11-10
- Accession no.
- 0001829126-26-012414
- Original filing
- SEC EDGAR filing index
AI summary of the filing text. It can contain mistakes; the original filing is authoritative.
NeOnc discloses FDA meeting for NEO100 and CEO open-market share purchases
NeOnc announced that FDA granted a Type B End-of-Phase meeting, scheduled for early January 2027, to discuss a potential accelerated approval pathway for intranasal NEO100 in recurrent or progressive IDH-mutant grade 4 astrocytoma. Separately, CEO Amir F. Heshmatpour purchased 80,000 shares in open-market transactions totaling $269,082 using personal funds.
- FDA granted a Type B End-of-Phase meeting for intranasal NEO100, scheduled for early January 2027.
- The meeting concerns a potential accelerated approval pathway in recurrent or progressive IDH-mutant grade 4 astrocytoma.
- CEO Amir F. Heshmatpour purchased 80,000 shares on November 5, 6 and 9, 2026, totaling $269,082.
- Heshmatpour used personal funds; the Company issued no shares in connection with the transactions.
regulatoryother
Items reported
- Item 7.01: Regulation FD Disclosure
The company is making information public under Regulation FD, which requires broad public disclosure of material information shared with certain market participants. Investor presentations and press releases are common. Like Item 2.02, this information is generally "furnished" rather than "filed". - Item 9.01: Financial Statements and Exhibits
Lists the financial statements, pro forma information and exhibits filed with the report. It almost always accompanies another Item and is rarely news on its own.
Documents
| Type | Description | Document |
|---|---|---|
| 8-K | 8-K | neonctechnologies_8k.htm |
| EX-99.1 | EXHIBIT 99.1 | neonctechnologies_ex99-1.htm |
| EX-99.2 | EXHIBIT 99.2 | neonctechnologies_ex99-2.htm |
The summary above was generated by AI from the filing text and checked automatically against it. Read the original documents on SEC EDGAR. How to read an 8-K.